Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The future of peptide therapy for disc repair The field of peptide therapy for spinal disc repair is evolving rapidly
Research published in 2025 demonstrated significant improvements in muscle and joint inflammation, with athletes showing faster recovery times and reduced inflammatory markers compared to control groups
BPC-157 is a 15-residue pentadecapeptide, GEPPPGKPADDAGLV, CHNO, 1419.53 g/mol, CAS 137525-51-0
Patients typically report initial reduction in pain or improvement in mobility within 1 to 2 weeks of starting BPC-157, with substantial healing changes between weeks 4 and 8
US$ 23.54
US$ 27.18
US$ 27.15
US$ 22.59
